Home    Back

Allogeneic msc (allomsc)    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
49Systemic lupus erythematosus1

49. Systemic lupus erythematosus    [ 827 clinical trials,   638 drugs,   (DrugBank: 168 drugs),   108 drug target genes,   191 drug target pathways]
Searched query = "Systemic lupus erythematosus", "SLE"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 827 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00698191
(ClinicalTrials.gov)		March 200713/6/2008Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)Phase I/IIa: Allogeneic Bone Marrow Derived Mesenchymal Stem Cells Transplantation For Refractory Systemic Lupus ErythematosusRefractory Systemic Lupus ErythematosusBiological: Allogeneic MSC (AlloMSC)Nanjing Medical UniversityNational Natural Science Foundation of ChinaRecruiting15 Years70 YearsBoth20Phase 1;Phase 2China